Asia-Pacific CStone and Kimia Therapeutics partner to take first-in-class DDR-targeting oncology asset into Phase I in China and Australia – Dealroom News Team November 4, 2026 1 minute read CStone and Kimia Therapeutics partner to take first-in-class DDR-targeting oncology asset into Phase I in China and Australia Dealroomsource About the Author News Team Administrator View All Posts Post navigation Previous: FG hails Adamu’s appointment as CAF SG, reaffirms Nigeria’s commitment to sports diplomacy – Nigeria Football Federation (NFF)Next: Farage pinned his fortunes to Trump – now it’s triggered his downfall – The Independent Related Stories Asia-Pacific No Xi, but Li of China expected in PH-hosted Asean summit – Inquirer.net News Team November 4, 2026 Asia-Pacific 17 Fintech Companies in Australia to Know – Built In News Team November 4, 2026 Asia-Pacific Taiwan's Microip Posts Record NT$12.91 Million October Revenue, Up More Than 6-Fold Year-on-Year and Rising for Seventh Straight Month – BigGo Finance News Team November 4, 2026
